The Executive Committee Questions on Technology Supply-Chain Risk

What the Executive Committee Must Ask About Technology Dependencies

Most executive committees can describe technology risk in general terms, but few can name the specific vendors their own portfolio is quietly concentrated around. That gap is exactly what separates a reactive program from a strategically managed one.

What should the executive committee ask before renewal season?

Whether the portfolio has ever been mapped for shared technology dependency, and if not, why that gap still exists.

This is a simple question with an uncomfortable answer at most organizations, since the mapping work has rarely been prioritized before. Why reinsurance leaders misdiagnose technology supply-chain dependencies explains why this gap persists: underwriting files were never built to capture vendor overlap in the first place. Asking the question directly, at the executive level, is often what finally forces the mapping project to happen. Committees that wait for a loss to force this question end up asking it under far worse conditions.

Who owns technology supply-chain risk inside the organization?

Joint ownership between the Chief Underwriting Officer and the Chief Risk Officer, with neither one able to fully solve it alone.

The CUO controls what data gets captured at binding, which is the raw material needed to see vendor concentration at all. The CRO owns the quantification and aggregation methodology that turns that raw data into an actual exposure number. Without both functions engaged together, the mapping either never gets built or gets built without the modeling rigor needed to act on it. A single named executive sponsor, drawing on both functions, tends to work better than a shared but informal responsibility.

How should this shape reinsurance purchasing strategy?

By directing hedging spend at the specific concentration points the portfolio actually has, instead of buying broad, generic cover.

Once a reinsurer knows which cloud providers or software platforms carry the most aggregate exposure across its book, it can target retro or ILW structures at exactly those points. That is a more capital-efficient use of hedging spend than buying broad technology-risk cover based on assumption rather than data. The Third-Party SLA Deviation AI Agent can help identify which vendor relationships are already showing early signs of instability, ahead of the next renewal cycle. Purchasing decisions informed by real concentration data consistently outperform purchasing decisions made on general market assumptions.

What questions separate a mature program from a naive one?

Specificity: a mature program can name its top dependencies, while a naive one can only describe the risk category in the abstract.

Executives can use this table directly as a self-assessment before the next board or renewal meeting.

How should management report this risk upward to the board?

With a concentration map, not a narrative summary alone.

A narrative description of technology risk tells the board that a risk exists, but it does not tell them how large or how concentrated it is. A concentration map, showing the top shared dependencies by estimated exposure, gives the board something concrete to set risk appetite against. This should be updated at every renewal, since new business written and policies that lapse both shift where the concentration actually sits. Reporting it this way also strengthens the earnings conversation covered in the earnings-volatility effect of technology supply-chain dependencies.

What tradeoffs does concentration risk force onto strategy?

A direct tension between growing market share and limiting exposure to any single shared dependency.

Writing more business in a fast-growing sector often means writing more exposure to whatever technology stack that sector has standardized on. Executives have to decide explicitly how much of that trade-off they are willing to accept, rather than discovering the answer only after a correlated loss. This is not a reason to avoid growth, but it is a reason to grow with concentration limits built in from the start. Programs that ignore this trade-off tend to find their growth was more correlated than it looked at the time.

How should this influence vendor and cloud provider selection?

Indirectly, by shaping how much aggregate exposure a reinsurer is willing to hold to any one vendor, not by dictating individual policyholder choices.

A reinsurer cannot and should not tell its cedants' policyholders which cloud provider to use. What it can do is set internal limits on how much of its own book it is willing to have exposed to any single vendor's failure. The Cloud Security Posture Assessment AI Agent can inform underwriting of individual accounts, feeding into that aggregate limit rather than replacing it. This distinction, between individual underwriting and portfolio-level limit setting, is where mature programs differ most from naive ones.

How should this influence conversations with reinsurance brokers at renewal?

Executives should ask brokers directly what technology-concentration data they hold on the placements being offered, rather than assuming brokers have already screened for it.

Brokers are naturally focused on securing competitive price and terms for a placement, which is not the same thing as screening for shared vendor concentration. Asking the question directly at renewal signals to the broking market that this data matters to how a reinsurer evaluates a submission. Over time, that kind of pressure from buyers raises the baseline amount of technology-dependency data the broking market is willing to share proactively. Executives who never ask this question will keep receiving submissions that were never screened for it in the first place.

What competitive advantage does a mature program create at renewal?

A reinsurer that can quantify its own technology concentration can negotiate more precisely and price more competitively than one relying on assumption.

Precise concentration data supports sharper terms, since underwriting can distinguish between a submission that adds genuine diversification and one that simply adds more exposure to an already-concentrated vendor. Cedants and brokers increasingly favor counterparties who can speak specifically to this risk, rather than offering only generic reassurance about technology risk management. Being an early mover on this kind of data discipline is a market differentiator, not just a defensive risk-management measure. Programs that treat this only as a compliance exercise are leaving a genuine competitive advantage on the table.

How should this executive discussion extend to reinsurance purchased on the reinsurer's own behalf?

Executives should apply the same concentration lens to the technology vendors underpinning their own operations, not only to the vendors sitting inside the underwritten portfolio.

A reinsurer's own policy administration, claims, and analytics systems often depend on the same small pool of cloud and software vendors it is analyzing in its book. An outage at one of those vendors could disrupt the reinsurer's own claims handling and reporting at exactly the moment a correlated market event is testing its portfolio. Treating operational technology dependency and underwritten technology dependency as one combined executive conversation, rather than two separate topics, closes a gap many programs still overlook.

How should this be discussed with rating agencies during routine reviews?

Proactively raising technology concentration data during routine rating reviews, rather than waiting to be asked, signals a mature and well-governed program.

Rating agencies are increasingly likely to ask about shared technology dependency even when a reinsurer has not raised the topic itself. Being the party that introduces the data first, complete with concentration figures and mitigation steps, tends to shape the conversation more favorably than responding reactively to a question the agency raises unprompted. Executive teams that treat this as a standing agenda item for every rating review are less likely to be caught without a ready answer.

How should this factor into decisions about which markets or segments to grow into?

Entering a segment concentrated around one dominant technology stack should be weighed against the concentration it adds, not evaluated on growth potential alone.

A fast-growing segment that has broadly standardized on a single cloud provider or software platform looks attractive purely on growth metrics. Written without a concentration lens, that same growth can quietly push the portfolio's technology dependency well past what the board's risk appetite would otherwise allow. Weighing growth opportunities against their concentration impact does not mean avoiding attractive segments, but it does mean pricing and structuring that growth with the added dependency explicitly accounted for. Segments evaluated only on growth potential, without this check, are the ones most likely to surprise an executive committee later.

What does the executive committee need to revisit every renewal cycle?

The concentration map itself, since it changes every year as the book changes.

A map built once and never updated becomes stale almost immediately, given how fast technology adoption shifts across an industry. Revisiting it at every renewal keeps the executive committee's questions grounded in the current portfolio, not last year's. This same discipline of continuous review applies to the operating controls covered in how to build an early-warning system for technology supply-chain dependencies, and to the governance cadence discussed in the risk-appetite test for technology supply-chain dependencies.

The executive committee that can answer these questions with specific vendor names and numbers is managing this risk. The one that can only describe it in general terms is still waiting to be surprised by it.

Sources

• Moody's RMS, "Introducing Moody's RMS Cyber Solutions Version 10.0"
• Bank of England / PRA, "Operational resilience: Critical third parties to the UK financial sector" (CP26/23)